These analogs effectively suppress NF-κB activation, reduce the production of pro-inflammatory cytokines, and attenuate oxidative stress-induced cellular damage compared with other compounds (Table 1), demonstrating greater efficacy in ameliorating insulin resistance and hepatic injury [87]. The gene discussed is NFKB1; the disease is Insulin resistance.